To hear about similar clinical trials, please enter your email below
Trial Title:
Liquid Biopsy Collection Study
NCT ID:
NCT06068348
Condition:
Chaperonin-Containing TCP-1
Circulating Tumor Cells
CCT
CTC
Conditions: Official terms:
Neoplastic Cells, Circulating
Conditions: Keywords:
Healthy
Study type:
Observational
Overall status:
Recruiting
Study design:
Time perspective:
Cross-Sectional
Summary:
The purpose of this study is to develop a liquid biopsy approach for detection of
circulating tumor cells (CTC) that could be used in place of the more invasive and
potentially risky methods of tissue biopsy. The aims of the project are: (a) determine
whether the Chaperonin-Containing TCP-1 (CCT) chaperonin can used to identify rare cancer
cells in blood, and (b) establish whether the cancer cells detected using the CCT
chaperonin for identification have invasive or metastatic potential.
Criteria for eligibility:
Study pop:
The researchers anticipate that the sample size of 60 will be adequate for statistical
analysis.
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Male or female
- Age greater than or equal to 18 and less than or equal to 80 years.
Exclusion Criteria:
- Adults unable to give informed consent
- Individuals who are not yet adults (infants, children, teenagers; under the age of
18)
- Individuals who weigh less than 110 lbs (as standard clinically advised to not give
blood)
- Pregnant women (due to hormonal changes in blood)
- Prisoners
- Persons reporting a current microbial (bacterial, viral, or fungal) infections
- Persons reporting that they are current taking antibiotic medications
- Persons with body temperatures above 99oF (indicating a fever)
Gender:
All
Minimum age:
18 Years
Maximum age:
80 Years
Healthy volunteers:
Accepts Healthy Volunteers
Locations:
Facility:
Name:
University of Central Florida
Address:
City:
Orlando
Zip:
32816
Country:
United States
Status:
Recruiting
Investigator:
Last name:
Annette Khaled, PhD
Email:
Principal Investigator
Start date:
October 7, 2021
Completion date:
October 2024
Lead sponsor:
Agency:
University of Central Florida
Agency class:
Other
Source:
University of Central Florida
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT06068348
